NMP22 BLADDERCHEK TEST TO BE INTRODUCED TO U.S. GYNECOLOGISTS

Matritech, a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, announced today that the NMP22 BladderChek Test will be exhibited for the first time at a U.S. gynecology conference. The test will be featured in an exhibit at the American College of Obstetricians and Gynecologists (ACOG) annual meeting in Washington, D.C.
Business Wire